Jeffrey Dierks's most recent trade in Harmony Biosciences Holdings Inc was a trade of 4,869 Common Stock done at an average price of $8.2 . Disclosure was reported to the exchange on March 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.22 per share. | 03 Mar 2025 | 4,869 | 4,869 | - | 8.2 | 40,023 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 4,869 | 0 | - | - | Stock Option | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 32.61 per share. | 03 Mar 2025 | 4,369 | 500 | - | 32.6 | 142,474 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 33.23 per share. | 03 Mar 2025 | 500 | 0 | - | 33.2 | 16,615 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 47,200 | 47,200 | - | - | Stock Option | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 13,450 | 13,450 | - | - | Restricted Stock Units | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.69 per share. | 24 Jan 2025 | 13,125 | 13,125 | - | 30.7 | 402,806 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jan 2025 | 13,125 | 39,375 | - | - | Stock Option | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 36.94 per share. | 24 Jan 2025 | 8,000 | 5,125 | - | 36.9 | 295,531 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 37.87 per share. | 24 Jan 2025 | 5,125 | 0 | - | 37.9 | 194,103 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jan 2025 | 2,687 | 2,687 | - | 0 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jan 2025 | 2,687 | 8,063 | - | - | Restricted Stock Units | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 38.02 per share. | 24 Jan 2025 | 1,629 | 0 | - | 38.0 | 61,941 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.01 per share. | 24 Jan 2025 | 1,058 | 1,629 | - | 38.0 | 40,215 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.44 per share. | 16 Jan 2025 | 29,475 | 29,475 | - | 33.4 | 985,644 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 37.41 per share. | 16 Jan 2025 | 29,475 | 0 | - | 37.4 | 1,102,795 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2025 | 29,475 | 6,738 | - | - | Stock Option | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2025 | 1,123 | 5,615 | - | - | Stock Option | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.44 per share. | 16 Jan 2025 | 1,123 | 1,123 | - | 33.4 | 37,553 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 16 Jan 2025 | 1,123 | 0 | - | 40 | 44,920 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.44 per share. | 15 Jan 2025 | 10,507 | 10,507 | - | 33.4 | 351,354 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 37.01 per share. | 15 Jan 2025 | 10,507 | 0 | - | 37.0 | 388,841 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 10,507 | 36,213 | - | - | Stock Option | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.44 per share. | 13 Jan 2025 | 7,180 | 7,180 | - | 33.4 | 240,099 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 37.04 per share. | 13 Jan 2025 | 7,180 | 0 | - | 37.0 | 265,946 | Common Stock |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2025 | 7,180 | 46,720 | - | - | Stock Option | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 29 Oct 2024 | 21,496 | 21,496 | - | 24 | 515,904 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 29 Oct 2024 | 21,496 | 28,972 | - | - | Stock Option | ||
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 29 Oct 2024 | 21,496 | 0 | - | 40.5 | 870,018 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 03 Oct 2024 | 35,652 | 705 | - | 35.0 | 1,249,435 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 03 Oct 2024 | 705 | 0 | - | 35.6 | 25,111 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 01 Oct 2024 | 400 | 400 | - | 24 | 9,600 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 01 Oct 2024 | 400 | 50,468 | - | - | Stock Option | ||
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 01 Oct 2024 | 400 | 0 | - | 40.2 | 16,077 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 30 Sep 2024 | 60,000 | 90,000 | - | - | Restricted Stock Units | ||
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 30 Sep 2024 | 60,000 | 60,000 | - | 0 | Common Stock | ||
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 30 Sep 2024 | 35,846 | 50,868 | - | - | Stock Option | ||
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 30 Sep 2024 | 35,846 | 0 | - | 40.0 | 1,434,951 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 30 Sep 2024 | 35,846 | 35,846 | - | 24 | 860,304 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 30 Sep 2024 | 23,643 | 36,357 | - | 40 | 945,720 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 27 Sep 2024 | 200 | 200 | - | 24 | 4,800 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 27 Sep 2024 | 200 | 86,714 | - | - | Stock Option | ||
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 27 Sep 2024 | 200 | 0 | - | 40.0 | 8,009 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 15 Mar 2024 | 11,979 | 11,979 | - | 8.2 | 98,467 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 15 Mar 2024 | 11,979 | 0 | - | 32 | 383,328 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 15 Mar 2024 | 9,644 | 4,869 | - | - | Stock Option | ||
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 15 Mar 2024 | 2,335 | 0 | - | - | Stock Option | ||
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 08 Mar 2024 | 194 | 0 | - | 32 | 6,208 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 08 Mar 2024 | 194 | 194 | - | 8.2 | 1,595 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 08 Mar 2024 | 100 | 2,335 | - | - | Stock Option | ||
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 08 Mar 2024 | 94 | 14,513 | - | - | Stock Option | ||
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 24 Jan 2024 | 52,500 | 52,500 | - | - | Stock Option | ||
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 24 Jan 2024 | 10,750 | 10,750 | - | - | Restricted Stock Units | ||
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 03 Oct 2022 | 12,173 | 12,173 | - | 8.2 | 100,062 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 03 Oct 2022 | 9,739 | 0 | - | - | Stock Option | ||
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 03 Oct 2022 | 9,382 | 2,791 | - | 44.4 | 417,004 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 03 Oct 2022 | 2,791 | 0 | - | 45.5 | 126,912 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 03 Oct 2022 | 2,434 | 2,435 | - | - | Stock Option | ||
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 22 Aug 2022 | 28,971 | 86,914 | - | - | Stock Option | ||
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 22 Aug 2022 | 28,971 | 28,971 | - | 24 | 695,304 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 22 Aug 2022 | 26,650 | 2,321 | - | 47.0 | 1,251,332 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 22 Aug 2022 | 2,321 | 0 | - | 47.6 | 110,395 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | Chief Commercial Officer | 01 Apr 2022 | 14,471 | 116,085 | - | - | Stock Option | ||
| Harmony Biosciences Holdin... | Jeffrey Dierks | Chief Commercial Officer | 01 Apr 2022 | 14,471 | 14,471 | - | 24 | 347,304 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | Chief Commercial Officer | 01 Apr 2022 | 7,706 | 0 | - | 49.9 | 384,277 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | Chief Commercial Officer | 01 Apr 2022 | 6,765 | 7,706 | - | 49.4 | 333,893 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | Chief Commercial Officer | 28 Feb 2022 | 10,041 | 0 | - | 40.0 | 401,653 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | Chief Commercial Officer | 28 Feb 2022 | 10,041 | 130,556 | - | - | Stock Option | ||
| Harmony Biosciences Holdin... | Jeffrey Dierks | Chief Commercial Officer | 28 Feb 2022 | 10,041 | 10,041 | - | 24 | 240,984 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | Chief Commercial Officer | 28 Feb 2022 | 4,869 | 14,607 | - | - | Stock Option | ||
| Harmony Biosciences Holdin... | Jeffrey Dierks | Chief Commercial Officer | 28 Feb 2022 | 4,869 | 0 | - | 40.0 | 194,958 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | Chief Commercial Officer | 28 Feb 2022 | 4,869 | 4,869 | - | 8.2 | 40,023 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | Chief Commercial Officer | 16 Feb 2022 | 4,259 | 0 | - | 40.1 | 170,591 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | Chief Commercial Officer | 16 Feb 2022 | 4,259 | 140,597 | - | - | Stock Option | ||
| Harmony Biosciences Holdin... | Jeffrey Dierks | Chief Commercial Officer | 16 Feb 2022 | 4,259 | 0 | - | 40.0 | 170,424 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | Chief Commercial Officer | 16 Feb 2022 | 4,259 | 4,259 | - | 24 | 102,216 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | Chief Commercial Officer | 16 Feb 2022 | 200 | 140,397 | - | - | Stock Option | ||
| Harmony Biosciences Holdin... | Jeffrey Dierks | Chief Commercial Officer | 16 Feb 2022 | 200 | 200 | - | 24 | 4,800 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | Director, Chief Commercial Officer | 06 Jan 2022 | 6,125 | 6,125 | - | 8.2 | 50,348 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | Director, Chief Commercial Officer | 06 Jan 2022 | 4,302 | 424 | - | 40.5 | 174,379 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | Director, Chief Commercial Officer | 06 Jan 2022 | 3,690 | 9,739 | - | - | Stock Option | ||
| Harmony Biosciences Holdin... | Jeffrey Dierks | Director, Chief Commercial Officer | 06 Jan 2022 | 2,435 | 4,869 | - | - | Stock Option | ||
| Harmony Biosciences Holdin... | Jeffrey Dierks | Director, Chief Commercial Officer | 06 Jan 2022 | 1,399 | 4,726 | - | 39.6 | 55,396 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | Director, Chief Commercial Officer | 06 Jan 2022 | 424 | 0 | - | 41.2 | 17,482 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | Chief Commercial Officer | 01 Nov 2021 | 10,000 | 10,000 | - | 8.2 | 82,200 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | Chief Commercial Officer | 01 Nov 2021 | 7,054 | 2,946 | - | 41.4 | 291,725 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | Chief Commercial Officer | 01 Nov 2021 | 6,048 | 13,429 | - | - | Stock Option | ||
| Harmony Biosciences Holdin... | Jeffrey Dierks | Chief Commercial Officer | 01 Nov 2021 | 3,952 | 19,476 | - | - | Stock Option | ||
| Harmony Biosciences Holdin... | Jeffrey Dierks | Chief Commercial Officer | 01 Nov 2021 | 2,946 | 0 | - | 42.4 | 125,015 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | Chief Commercial Officer | 07 Sep 2021 | 5,000 | 5,000 | - | 8.2 | 41,100 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | Chief Commercial Officer | 07 Sep 2021 | 5,000 | 0 | - | 37 | 185,000 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | Chief Commercial Officer | 07 Sep 2021 | 4,083 | 7,304 | - | - | Stock Option | ||
| Harmony Biosciences Holdin... | Jeffrey Dierks | Chief Commercial Officer | 07 Sep 2021 | 917 | 23,428 | - | - | Stock Option | ||
| Harmony Biosciences Holdin... | Jeffrey Dierks | Chief Commercial Officer | 01 Sep 2021 | 10,000 | 10,000 | - | 8.2 | 82,200 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | Chief Commercial Officer | 01 Sep 2021 | 10,000 | 18,692 | - | - | Stock Option | ||
| Harmony Biosciences Holdin... | Jeffrey Dierks | Chief Commercial Officer | 01 Sep 2021 | 6,698 | 3,302 | - | 33.3 | 223,010 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | Chief Commercial Officer | 01 Sep 2021 | 3,302 | 0 | - | 34.3 | 113,115 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | Chief Commercial Officer | 26 Aug 2021 | 3,400 | 28,692 | - | - | Stock Option | ||
| Harmony Biosciences Holdin... | Jeffrey Dierks | Chief Commercial Officer | 26 Aug 2021 | 3,400 | 0 | - | 35.2 | 119,604 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | Chief Commercial Officer | 26 Aug 2021 | 3,400 | 3,400 | - | 8.2 | 27,948 | Common Stock | |
| Harmony Biosciences Holdin... | Jeffrey Dierks | Chief Commercial Officer | 26 Aug 2021 | 1,600 | 0 | - | 35.0 | 56,021 | Common Stock |